Zygem Strengthens its Worldwide Presence with new Distribution Agreements in Asia Pacific Markets
News May 19, 2009
ZyGEM Corp. Ltd. has announced it has entered into a number of new agreements that strengthen its market presence in the Asia Pacific region. These include distribution agreements for its innovative DNA extraction kits in China and South Korea and partnerships in New Zealand and parts of Australia to broaden the company’s product offerings in its home market.
These new agreements build on the early success of ZyGEM’s recent major distribution agreements for its DNA extraction kits in the Americas and Europe with a leading life science products distributor.
These new agreements include exclusive distribution rights for ZyGEM’s full line of DNA extraction kits-in China, through Shanghai Sangon Biological Engineering Technology & Services Co., Ltd. (Sangon) and in South Korea, through SolGent Inc.
In addition, in New Zealand and certain parts of Australia, ZyGEM is now co-distributing custom oligonucleotides from Integrated DNA Technologies, Inc., PCR reagents from Quanta Biosciences, sample storage products from Biomatrica, Inc., and laboratory microplates from Porvair Sciences.
“ZyGEM’s recently announced distribution agreements for our DNA extraction kits in the Americas and Europe provide us with an exceptionally strong distribution channel in the northern hemisphere, and this is already starting to pay dividends in terms of revenues and market penetration,” said Paul Kinnon, CEO of ZyGEM. “These agreements also give us an ideal channel to promote ZyGEM’s planned new products as they are released over the course of the year.”
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Gene-edited Pigs are Resistant to Billion-dollar VirusNews
Scientists have produced pigs that can resist one of the world’s most costly animal diseases, by changing their genetic code. Tests with the virus – called Porcine Reproductive and Respiratory Syndrome, or PRRS – found the pigs do not become infected at all. The animals show no signs that the change in their DNA has had any other impact on their health or wellbeing.READ MORE
Eating Activates Calorie-Burning FatNews
The importance of the human brown adipose tissue (BAT) has become clearer during the past ten years. Coldness is one of the most effective activators of the BAT metabolic function but, in rodents, eating has also been shown to activate BAT. The debate on whether eating has the same effect on humans has lasted for decades. Now, the researchers at Turku PET Centre have proven that having a meal increases oxygen consumption in human BAT to the same extent as coldness.READ MORE